MUC1 and pancreatic neoplasm: CA 19–9, a sialylated Lewis (Lea) antigen of the MUC1 protein, is another prognostic marker in pancreatic cancer, and serial measurements of CA 19–9 have been shown to be useful to monitor treatment response [41,42].